国际药物开发与研究杂志

  • 国际标准期刊号: 0975-9344
  • 期刊 h 指数: 44
  • 期刊引用分数: 59.93
  • 期刊影响因子: 48.80
索引于
  • Genamics 期刊搜索
  • 中国知网(CNKI)
  • 引用因子
  • 西马戈
  • 研究期刊索引目录 (DRJI)
  • OCLC-WorldCat
  • 普布隆斯
  • 米亚尔
  • 大学教育资助委员会
  • 欧洲酒吧
  • 谷歌学术
  • 夏尔巴罗密欧
  • 秘密搜索引擎实验室
  • 研究之门
分享此页面

抽象的

Recent Findings and Development of 3D Printing Technology in Pharmaceutical
Formulation Development: An Extensive Review

Sankha Bhattacharya*, Sushil Kumar Singh, Shubham Shrestha, Yudhishthir Singh Baghel, Debalina Maity, Akhil Kumar, Ghanshyam Das Gupta, Raj Kumar Narang, Gaurav Goyal and Sourabh Kosey

Three-dimensional (3D) printing technology is an emerging and flourishing technique which has a tremendous
potential to bring a paradigm shift in the pharmaceutical sector. Basically, 3D printing is a fabrication technique in
which automatically layer-by-layer materials are being deposited to create various design of choice. The primary
objective of this manuscript is to discuss modern methods, techniques, and current trends, polymers of choice and
recent applications of 3D printing technology applying in the pharmaceutical sector. Recently, the FDA has approved
3D printed tablet called Spritam, which brings a tremendous boost in the preparation of fabricated drug delivery
system and personalized medicine. In this review, special importance was given to highlight the challenges and
future perspectives of 3D printed technology in the pharmaceutical sector.